 | • レポートコード：MRC2Q12-17017 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、生体血管パッチのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 生体血管パッチのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生体血管パッチの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生体血管パッチのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの生体血管パッチの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の生体血管パッチの売上および2028年までの予測に焦点を当てています。 生体血管パッチのグローバル主要企業には、Lemaitre Vascular、Baxter、Maquet、Admedus、Cryolife、Edwards Lifesciences、Labcor、Terumo Corporationなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 生体血管パッチ市場は、タイプとアプリケーションによって区分されます。世界の生体血管パッチ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 コーティング式、非コーティング式 【アプリケーション別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 生体血管パッチ製品概要 - タイプ別市場（コーティング式、非コーティング式） - アプリケーション別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の生体血管パッチ販売量予測2017-2028 - 世界の生体血管パッチ売上予測2017-2028 - 生体血管パッチの地域別販売量 - 生体血管パッチの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別生体血管パッチ販売量 - 主要メーカー別生体血管パッチ売上 - 主要メーカー別生体血管パッチ価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（コーティング式、非コーティング式） - 生体血管パッチのタイプ別販売量 - 生体血管パッチのタイプ別売上 - 生体血管パッチのタイプ別価格 ・アプリケーション別市場規模（病院、診療所、その他） - 生体血管パッチのアプリケーション別販売量 - 生体血管パッチのアプリケーション別売上 - 生体血管パッチのアプリケーション別価格 ・北米市場 - 北米の生体血管パッチ市場規模（タイプ別、アプリケーション別） - 主要国別の生体血管パッチ市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの生体血管パッチ市場規模（タイプ別、アプリケーション別） - 主要国別の生体血管パッチ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の生体血管パッチ市場規模（タイプ別、アプリケーション別） - 主要国別の生体血管パッチ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の生体血管パッチ市場規模（タイプ別、アプリケーション別） - 主要国別の生体血管パッチ市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの生体血管パッチ市場規模（タイプ別、アプリケーション別） - 主要国別の生体血管パッチ市場規模（トルコ、サウジアラビア） ・企業情報 Lemaitre Vascular、Baxter、Maquet、Admedus、Cryolife、Edwards Lifesciences、Labcor、Terumo Corporation ・産業チェーン及び販売チャネル分析 - 生体血管パッチの産業チェーン分析 - 生体血管パッチの原材料 - 生体血管パッチの生産プロセス - 生体血管パッチの販売及びマーケティング - 生体血管パッチの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 生体血管パッチの産業動向 - 生体血管パッチのマーケットドライバー - 生体血管パッチの課題 - 生体血管パッチの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Biologic Vascular Patch is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Biologic Vascular Patch is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Biologic Vascular Patch is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Biologic Vascular Patch include Lemaitre Vascular, Baxter, Maquet, Admedus, Cryolife, Edwards Lifesciences, Labcor and Terumo Corporation, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Biologic Vascular Patch manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Biologic Vascular Patch market. Further, it explains the major drivers and regional dynamics of the global Biologic Vascular Patch market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Lemaitre Vascular
Baxter
Maquet
Admedus
Cryolife
Edwards Lifesciences
Labcor
Terumo Corporation
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Biologic Vascular Patch Segment by Type
Coated
Uncoated
Biologic Vascular Patch Segment by Application
Hospital
Clinic
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Biologic Vascular Patch market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Biologic Vascular Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Biologic Vascular Patch, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Biologic Vascular Patch, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biologic Vascular Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Biologic Vascular Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Biologic Vascular Patch sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Lemaitre Vascular, Baxter, Maquet, Admedus, Cryolife, Edwards Lifesciences, Labcor and Terumo Corporation, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Biologic Vascular Patch in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Biologic Vascular Patch manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologic Vascular Patch sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Biologic Vascular Patch Product Introduction
1.2 Market by Type
1.2.1 Global Biologic Vascular Patch Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Coated
1.2.3 Uncoated
1.3 Market by Application
1.3.1 Global Biologic Vascular Patch Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biologic Vascular Patch Sales Estimates and Forecasts 2017-2028
2.2 Global Biologic Vascular Patch Revenue Estimates and Forecasts 2017-2028
2.3 Global Biologic Vascular Patch Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Biologic Vascular Patch Sales by Region
2.4.1 Global Biologic Vascular Patch Sales by Region (2017-2022)
2.4.2 Global Sales Biologic Vascular Patch by Region (2023-2028)
2.5 Global Biologic Vascular Patch Revenue by Region
2.5.1 Global Biologic Vascular Patch Revenue by Region (2017-2022)
2.5.2 Global Biologic Vascular Patch Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Biologic Vascular Patch Sales by Manufacturers
3.1.1 Global Top Biologic Vascular Patch Manufacturers by Sales (2017-2022)
3.1.2 Global Biologic Vascular Patch Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biologic Vascular Patch in 2021
3.2 Global Biologic Vascular Patch Revenue by Manufacturers
3.2.1 Global Biologic Vascular Patch Revenue by Manufacturers (2017-2022)
3.2.2 Global Biologic Vascular Patch Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Biologic Vascular Patch Revenue in 2021
3.3 Global Biologic Vascular Patch Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Biologic Vascular Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Biologic Vascular Patch Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biologic Vascular Patch Sales by Type
4.1.1 Global Biologic Vascular Patch Historical Sales by Type (2017-2022)
4.1.2 Global Biologic Vascular Patch Forecasted Sales by Type (2023-2028)
4.1.3 Global Biologic Vascular Patch Sales Market Share by Type (2017-2028)
4.2 Global Biologic Vascular Patch Revenue by Type
4.2.1 Global Biologic Vascular Patch Historical Revenue by Type (2017-2022)
4.2.2 Global Biologic Vascular Patch Forecasted Revenue by Type (2023-2028)
4.2.3 Global Biologic Vascular Patch Revenue Market Share by Type (2017-2028)
4.3 Global Biologic Vascular Patch Price by Type
4.3.1 Global Biologic Vascular Patch Price by Type (2017-2022)
4.3.2 Global Biologic Vascular Patch Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Biologic Vascular Patch Sales by Application
5.1.1 Global Biologic Vascular Patch Historical Sales by Application (2017-2022)
5.1.2 Global Biologic Vascular Patch Forecasted Sales by Application (2023-2028)
5.1.3 Global Biologic Vascular Patch Sales Market Share by Application (2017-2028)
5.2 Global Biologic Vascular Patch Revenue by Application
5.2.1 Global Biologic Vascular Patch Historical Revenue by Application (2017-2022)
5.2.2 Global Biologic Vascular Patch Forecasted Revenue by Application (2023-2028)
5.2.3 Global Biologic Vascular Patch Revenue Market Share by Application (2017-2028)
5.3 Global Biologic Vascular Patch Price by Application
5.3.1 Global Biologic Vascular Patch Price by Application (2017-2022)
5.3.2 Global Biologic Vascular Patch Price Forecast by Application (2023-2028)
6 North America
6.1 North America Biologic Vascular Patch Market Size by Type
6.1.1 North America Biologic Vascular Patch Sales by Type (2017-2028)
6.1.2 North America Biologic Vascular Patch Revenue by Type (2017-2028)
6.2 North America Biologic Vascular Patch Market Size by Application
6.2.1 North America Biologic Vascular Patch Sales by Application (2017-2028)
6.2.2 North America Biologic Vascular Patch Revenue by Application (2017-2028)
6.3 North America Biologic Vascular Patch Market Size by Country
6.3.1 North America Biologic Vascular Patch Sales by Country (2017-2028)
6.3.2 North America Biologic Vascular Patch Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Biologic Vascular Patch Market Size by Type
7.1.1 Europe Biologic Vascular Patch Sales by Type (2017-2028)
7.1.2 Europe Biologic Vascular Patch Revenue by Type (2017-2028)
7.2 Europe Biologic Vascular Patch Market Size by Application
7.2.1 Europe Biologic Vascular Patch Sales by Application (2017-2028)
7.2.2 Europe Biologic Vascular Patch Revenue by Application (2017-2028)
7.3 Europe Biologic Vascular Patch Market Size by Country
7.3.1 Europe Biologic Vascular Patch Sales by Country (2017-2028)
7.3.2 Europe Biologic Vascular Patch Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Biologic Vascular Patch Market Size by Type
8.1.1 Asia Pacific Biologic Vascular Patch Sales by Type (2017-2028)
8.1.2 Asia Pacific Biologic Vascular Patch Revenue by Type (2017-2028)
8.2 Asia Pacific Biologic Vascular Patch Market Size by Application
8.2.1 Asia Pacific Biologic Vascular Patch Sales by Application (2017-2028)
8.2.2 Asia Pacific Biologic Vascular Patch Revenue by Application (2017-2028)
8.3 Asia Pacific Biologic Vascular Patch Market Size by Region
8.3.1 Asia Pacific Biologic Vascular Patch Sales by Region (2017-2028)
8.3.2 Asia Pacific Biologic Vascular Patch Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Biologic Vascular Patch Market Size by Type
9.1.1 Latin America Biologic Vascular Patch Sales by Type (2017-2028)
9.1.2 Latin America Biologic Vascular Patch Revenue by Type (2017-2028)
9.2 Latin America Biologic Vascular Patch Market Size by Application
9.2.1 Latin America Biologic Vascular Patch Sales by Application (2017-2028)
9.2.2 Latin America Biologic Vascular Patch Revenue by Application (2017-2028)
9.3 Latin America Biologic Vascular Patch Market Size by Country
9.3.1 Latin America Biologic Vascular Patch Sales by Country (2017-2028)
9.3.2 Latin America Biologic Vascular Patch Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Biologic Vascular Patch Market Size by Type
10.1.1 Middle East and Africa Biologic Vascular Patch Sales by Type (2017-2028)
10.1.2 Middle East and Africa Biologic Vascular Patch Revenue by Type (2017-2028)
10.2 Middle East and Africa Biologic Vascular Patch Market Size by Application
10.2.1 Middle East and Africa Biologic Vascular Patch Sales by Application (2017-2028)
10.2.2 Middle East and Africa Biologic Vascular Patch Revenue by Application (2017-2028)
10.3 Middle East and Africa Biologic Vascular Patch Market Size by Country
10.3.1 Middle East and Africa Biologic Vascular Patch Sales by Country (2017-2028)
10.3.2 Middle East and Africa Biologic Vascular Patch Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Lemaitre Vascular
11.1.1 Lemaitre Vascular Corporation Information
11.1.2 Lemaitre Vascular Overview
11.1.3 Lemaitre Vascular Biologic Vascular Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Lemaitre Vascular Biologic Vascular Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Lemaitre Vascular Recent Developments
11.2 Baxter
11.2.1 Baxter Corporation Information
11.2.2 Baxter Overview
11.2.3 Baxter Biologic Vascular Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Baxter Biologic Vascular Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter Recent Developments
11.3 Maquet
11.3.1 Maquet Corporation Information
11.3.2 Maquet Overview
11.3.3 Maquet Biologic Vascular Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Maquet Biologic Vascular Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Maquet Recent Developments
11.4 Admedus
11.4.1 Admedus Corporation Information
11.4.2 Admedus Overview
11.4.3 Admedus Biologic Vascular Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Admedus Biologic Vascular Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Admedus Recent Developments
11.5 Cryolife
11.5.1 Cryolife Corporation Information
11.5.2 Cryolife Overview
11.5.3 Cryolife Biologic Vascular Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Cryolife Biologic Vascular Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cryolife Recent Developments
11.6 Edwards Lifesciences
11.6.1 Edwards Lifesciences Corporation Information
11.6.2 Edwards Lifesciences Overview
11.6.3 Edwards Lifesciences Biologic Vascular Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Edwards Lifesciences Biologic Vascular Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Edwards Lifesciences Recent Developments
11.7 Labcor
11.7.1 Labcor Corporation Information
11.7.2 Labcor Overview
11.7.3 Labcor Biologic Vascular Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Labcor Biologic Vascular Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Labcor Recent Developments
11.8 Terumo Corporation
11.8.1 Terumo Corporation Corporation Information
11.8.2 Terumo Corporation Overview
11.8.3 Terumo Corporation Biologic Vascular Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Terumo Corporation Biologic Vascular Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Terumo Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biologic Vascular Patch Industry Chain Analysis
12.2 Biologic Vascular Patch Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biologic Vascular Patch Production Mode & Process
12.4 Biologic Vascular Patch Sales and Marketing
12.4.1 Biologic Vascular Patch Sales Channels
12.4.2 Biologic Vascular Patch Distributors
12.5 Biologic Vascular Patch Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Biologic Vascular Patch Industry Trends
13.2 Biologic Vascular Patch Market Drivers
13.3 Biologic Vascular Patch Market Challenges
13.4 Biologic Vascular Patch Market Restraints
14 Key Findings in The Global Biologic Vascular Patch Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer